Related Experiment Video

Updated: Jun 16, 2026

The Adjuvant Efficacy of Angong Niuhuang Pill in the Treatment of Viral Encephalitis: A Meta-Analysis of Randomized Controlled Trials
08:36

The Adjuvant Efficacy of Angong Niuhuang Pill in the Treatment of Viral Encephalitis: A Meta-Analysis of Randomized Controlled Trials

Published on: April 19, 2024

Inconsistent trial assessments by the National Institute for Health and Clinical Excellence and IQWiG: standards for

J Hasford1, P Bramlage, G Koch

  • 1Institut für Medizinische Informationsverarbeitung, Biometrie und Epidemiologie, LMU München, Marchioninistrasse 15, Munich, Germany. has@ibe.med.uni-muenchen.de

Journal of Clinical Epidemiology
|February 23, 2010
PubMed

Insights

Discrepancies in evaluating medical interventions exist, even when standards are similar. Different interpretations of subgroup analyses, like in the CAPRIE trial, highlight the need for unified international guidelines on heterogeneity assessment.

Area of Science:

  • Health Services Research
  • Clinical Trial Methodology
  • Regulatory Science

Background:

  • Established methodologies exist for critically assessing medical interventions.
  • Regulatory agencies generally adhere to consistent standards for intervention assessment.
  • Practical application of these standards can lead to inconsistencies.

Purpose of the Study:

  • To examine discrepancies in the interpretation of subgroup analyses in medical interventions.
  • To illustrate a lack of consensus in evaluating treatment comparisons across patient subgroups.
  • To highlight the need for standardized international guidelines.

Main Methods:

  • Comparative analysis of the evaluation of the CAPRIE trial by two regulatory bodies: NICE (UK) and IQWiG (Germany).
  • Focus on the interpretation of heterogeneity in treatment effects across subgroups.
  • Examination of the Clopidogrel versus Aspirin in Patients at risk of Ischemic Events (CAPRIE) trial data.

Main Results:

  • NICE concluded CAPRIE showed overall clinical benefit in the intention-to-treat (ITT) population, robust to heterogeneity.
  • IQWiG interpreted heterogeneity as limiting clinical benefit to specific subgroups with statistically significant results, disregarding the ITT analysis.
  • Divergent conclusions arose from differing interpretations of subgroup analysis and heterogeneity.

Conclusions:

  • International standards are required for conducting and interpreting subgroup analyses in clinical trials.
  • Standardized approaches are needed for assessing heterogeneity between strata.
  • Harmonized guidelines would improve consistency in the critical appraisal of medical interventions.
Abstract

Related Concept Videos

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
Cochran's Q Test01:17

Cochran's Q Test

Cochran's Q Test is a nonparametric statistical test used to determine if there are potential differences in the outcomes of three or more related groups on a binary (yes/no) or dichotomous outcome. It is essentially an extension of the McNemar Test, which is limited to two related samples - Cochran's Q test can handle three or more related samples, making it more versatile in scenarios where subjects are measured under multiple conditions. The test statistic follows a Chi-Square distribution,...
Bias in Epidemiological Studies01:29

Bias in Epidemiological Studies

Biases can arise at various stages of research, from study design and data collection to analysis and interpretation. Recognizing and addressing these biases is essential to ensure the validity and reliability of epidemiological findings.Broadly speaking, biases in epidemiology fall into three main categories: selection bias, information bias, and confounding. A more detailed description of possible biases is:
Bioequivalence Data: Statistical Interpretation01:16

Bioequivalence Data: Statistical Interpretation

The statistical interpretation of bioequivalence data is a significant aspect of pharmaceutical research. Bioequivalence refers to the absence of any significant difference in the rate and extent to which the active ingredient in pharmaceutical products becomes available at the site of drug action when administered at the same molar dose under similar conditions. This helps determine if different drug products have similar absorption rates, ensuring their interchangeability.Statistical...
Bioequivalence studies: Biowaivers01:13

Bioequivalence studies: Biowaivers

In certain scenarios, in vitro dissolution tests can replace in vivo bioequivalence studies. This is particularly true when a drug product, though available in varying strengths, maintains proportional similarity in its active and inactive ingredients. In such cases, the need for in vivo bioequivalence studies for lower strength variants may be waived, provided dissolution tests and in vivo studies on the highest strength yield satisfactory results.Bioequivalence can be indicated through...
Confounding in Epidemiological Studies01:27

Confounding in Epidemiological Studies

Confounding in statistical epidemiology represents a pivotal challenge, referring to the distortion in the perceived relationship between an exposure and an outcome due to the presence of a third variable, known as a confounder. This variable is associated with both the exposure and the outcome but is not a direct link in their causal chain. Its presence can lead to erroneous interpretations of the exposure's effect, either exaggerating or underestimating the true association. This phenomenon...